Clarivate expands partnership with verisim life to accelerate and de-risk research and drug development

New ai-enabled, integrated workflow provides pharma and biotech companies with comprehensive r&d insights to help minimize late-stage failures during clinical trials london , dec. 5, 2023 /prnewswire/ --  clarivate plc (nyse:clvt), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the launch of verisim life translational index™ on cortellis drug discovery intelligence by clarivate. the integrated workflow provides customers with a diverse array of predictive compound safety and efficacy insights, including bioavailability, hepatic and renal clearance, clinical toxicity, first-in-human dose and more.
CLVT Ratings Summary
CLVT Quant Ranking